Abstract

The cutaneous apocrine carcinomas are malignant tumors rare adnexal, slowly and preferably located in the axillary growth. A girl aged 24 with no particular medical history was addressed to a right axillary mass slowly evolving for two years, associated with pain in the right upper limb. The echo mammogram had shown a mass in the axilla and supraclavicular and axillary MRI had objectified mass axillary measuring 171mm. Pathological examination with immunostaining was in favor of apocrine carcinoma. The cutaneous apocrine carcinomas are well-known in the mammary glands, but it is difficult to morphologically distinguish between breast cancer and apocrine carcinoma. Pan African Medical Journal 2016; 2

Highlights

  • The cutaneous apocrine carcinoma is a rare malignant adnexal tumor

  • We report the case of axillary apocrine carcinoma skin in a girl aged 24

  • A breast MRI scan done after 6 cycles of chemotherapy objectified axillary mass measuring 161/90 mm coming in contact with the right axillary pedicle remained permeable

Read more

Summary

Introduction

The cutaneous apocrine carcinoma is a rare malignant adnexal tumor. They are located preferentially in the axilla. We report the case of axillary apocrine carcinoma skin in a girl aged 24. This is a girl aged 24, without specific medical history, which arose in consultation for a right axillary mass gradually increasing volume for two years without inflammatory signs operating in a context of conservation general condition. A breast MRI scan done after 6 cycles of chemotherapy objectified axillary mass measuring 161/90 mm coming in contact with the right axillary pedicle remained permeable. Surgery was discussed at this stage but challenged seen the intimate contact of the tumor mass with large axillary vessels. A copy of the written consent is available of review by the editor in chief of this journal

Discussion
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call